Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections

Journal of Virology

Volumn 82, Issue 1, 2008, Pages 254-267

  Domingo Gil, Elena ^a   Pérez Jiménez, Eva ^a   Ventoso, Iván ^a,b   Nájera, José L ^a   Esteban, Mariano ^a,c  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; DOUBLE STRANDED DNA; INTERFERON; PROTEIN KINASE R; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN E3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CELL POPULATION; CELL STRAIN BHK; CONTROLLED STUDY; DISEASE PREDISPOSITION; E3L GENE; ENZYME ANALYSIS; GENE EXPRESSION REGULATION; HOST RESISTANCE; IMMUNE RESPONSE; IN VIVO STUDY; INFECTION RESISTANCE; INFECTION SENSITIVITY; INOCULATION; INTERFERON PRODUCTION; LEISHMANIA MAJOR; LYMPH NODE; MOUSE; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; PROTEIN INDUCTION; SPLEEN; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; VACCINIA VIRUS; VIRUS GENE; VIRUS INFECTIVITY;

ANIMALS; BODY WEIGHT; CELL LINE; FEMALE; IMMUNITY, NATURAL; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LIVER; LYMPH NODES; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; OVARY; PARASITEMIA; RNA-BINDING PROTEINS; SPLEEN; T-LYMPHOCYTES; TAIL; VACCINIA; VACCINIA VIRUS; VIRAL PROTEINS;

ANIMALIA; LEISHMANIA MAJOR; MURINAE; MUS; MUS MUSCULUS; VACCINIA VIRUS;

EID: 37349057476     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01384-07     Document Type: Article

References (51)

1. Alcami, A. 2003. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3:36-50.
2. Beattie, E., K. L. Denzler, J. Tartaglia, M. E. Perkus, E. Paoletti, and B. L. Jacobs. 1995. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69:499-505.
3. Beattie, E., E. B. Kauffman, H. Martinez, M. E. Perkus, B. L. Jacobs, E. Paoletti, and J. Tartaglia. 1996. Host-range restriction of vaccinia virus E3L-specific deletion mutants. Virus Genes 12:89-94.
4. Belding, D. L. 1965. Textbook of parasitology, 3rd ed., p. 217. Appleton-Century-Croft, New York, NY.
5. Biron, C. A. 1998. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10:383-390.
6. Bogdan, C., M. Rollinghoff, and A. Diefenbach. 2000. The role of nitric oxide in innate immunity. Immunol. Rev. 173:17-26.
7. Brandt, T., M. C. Heck, S. Vijaysri, G. M. Jentarra, J. M. Cameron, and B. L. Jacobs. 2005. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response. Virology 333:263-270.
8. Brandt, T. A., and B. L. Jacobs. 2001. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. J. Virol. 75:850-856.
9. Buffet, P. A., A. Sulahian, Y. J. Garin, N. Nassar, and F. Derouin. 1995. Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob. Agents Chemother. 39:2167-2168.
10. Chang, H. W., and B. L. Jacobs. 1993. Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA. Virology 194:537-547.
11. Chang, H. W., L. H. Uribe, and B. L. Jacobs. 1995. Rescue of vaccinia virus lacking the E3L gene by mutants of E3L. J. Virol. 69:6605-6608.
12. Chang, H. W., J. C. Watson, and B. L. Jacobs. 1992. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 89:4825-4829.
13. Davies, M. V., H. W. Chang, B. L. Jacobs, and R. J. Kaufman. 1993. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J. Virol. 67:1688-1692.
14. Der, S. D., A. Zhou, B. R. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95:15623-15628.
15. Diaz-Guerra, M., C. Rivas, and M. Esteban. 1997. Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology 236:354-363.
16. Diaz-Guerra, M., C. Rivas, and M. Esteban. 1997. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology 227:220-228.
17. Garcia, M. A., J. Gil, I. Ventoso, S. Guerra, E. Domingo, C. Rivas, and M. Esteban. 2006. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 70:1032-1060.
18. Garcia, M. A., S. Guerra, J. Gil, V. Jimenez, and M. Esteban. 2002. Antiapoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L. Oncogene 21:8379-8387.
19. Goodbourn, S., L. Didcock, and R. E. Randall. 2000. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81:2341-2364.
20. Haller, O., G. Kochs, and F. Weber. 2006. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344:119-130.
21. Hogan, B., F. Constantini, and E. Lacy. 1986. Manipulation of the mouse embryo. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
22. Kerr, I. M., P. J. Cayley, R. H. Silverman, and M. Knight. 1982. The antiviral action of interferon. Philos. Trans. R. Soc. Lond. B 299:59-67.
23. Kim, Y. G., K. Lowenhaupt, D. B. Oh, K. K. Kim, and A. Rich. 2004. Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo: implications for development of a therapy for poxvirus infection. Proc. Natl. Acad. Sci. USA 101:1514-1518.
24. Kim, Y. G., M. Muralinath, T. Brandt, M. Pearcy, K. Hauns, K. Lowenhaupt, B. L. Jacobs, and A. Rich. 2003. A role for Z-DNA binding in vaccinia virus pathogenesis. Proc. Natl. Acad. Sci. USA 100:6974-6979.
25. Kwon, J. A., and A. Rich. 2005. Biological function of the vaccinia virus Z-DNA-binding protein E3L: gene transactivation and antiapoptotic activity in HeLa cells. Proc. Natl. Acad. Sci. USA 102:12759-12764.
26. Langland, J. O., and B. L. Jacobs. 2004. Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L. Virology 324:419-429.
27. Langland, J. O., and B. L. Jacobs. 2002. The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. Virology 299:133-141.
28. Liu, Y., K. C. Wolff, B. L. Jacobs, and C. E. Samuel. 2001. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-1 editing activity. Virology 289:378-387.
29. Lucas, A., and G. McFadden. 2004. Secreted immunomodulatory viral proteins as novel biotherapeutics. J. Immunol. 173:4765-4774.
30. Marie, I., J. E. Durbin, and D. E. Levy. 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:6660-6669.
31. + T cells using an ELISPOT assay. J. Immunol. Methods 181:45-54.
32. Montoliu, L., T. Umland, and G. Schutz. 1996. A locus control region at - 12 kb of the tyrosinase gene. EMBO J. 15:6026-6034.
33. Prlic, M., J. Gibbs, and S. C. Jameson. 2005. Characteristics of NK cell migration early after vaccinia infection. J. Immunol. 175:2152-2157.
34. Ramirez, J. C., M. M. Gherardi, and M. Esteban. 2000. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine. J. Virol. 74:923-933.
35. Rice, C. M., R. Levis, J. H. Strauss, and H. V. Huang. 1987. Production of infectious RNA transcripts from Sindbis virus cDNA clones: mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants. J. Virol. 61:3809-3819.
36. Risco, C., J. R. Rodriguez, W. Demkowicz, R. Heljasvaara, J. L. Carrascosa, M. Esteban, and D. Rodriguez. 1999. The vaccinia virus 39-kDa protein forms a stable complex with the p4a/4a major core protein early in morphogenesis. Virology 265:375-386.
37. Rivas, C., J. Gil, Z. Melkova, M. Esteban, and M. Diaz-Guerra. 1998. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. Virology 243:406-414.
38. Rodriguez, J. F., D. Rodriguez, J. R. Rodriguez, E. B. McGowan, and M. Esteban. 1988. Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals. Proc. Natl. Acad. Sci. USA 85:1667-1671.
39. Romano, P. R., F. Zhang, S. L. Tan, M. T. Garcia-Barrio, M. G. Katze, T. E. Dever, and A. G. Hinnebusch. 1998. Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain. Mol. Cell. Biol. 18:7304-7316.
40. Sacks, D., and N. Noben-Trauth. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2:845-858.
41. Salazar-Mather, T. P., C. A. Lewis, and C. A. Biron. 2002. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J. Clin. Investig. 110:321-330.
42. Smith, E. J., I. Marie, A. Prakash, A. Garcia-Sastre, and D. E. Levy. 2001. IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by vaccinia virus E3L protein. J. Biol. Chem. 276:8951-8957.
43. Smith, G. L., J. A. Symons, A. Khanna, A. Vanderplasschen, and A. Alcami. 1997. Vaccinia virus immune evasion. Immunol. Rev. 159:137-154.
44. Smith, V. P., and A. Alcami. 2002. Inhibition of interferons by ectromelia virus. J. Virol. 76:1124-1134.
45. Thomis, D. C., and C. E. Samuel. 1993. Mechanism of interferon action: evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR. J. Virol. 67:7695-7700.
46. Ventoso, I., M. A. Sanz, S. Molina, J. J. Berlanga, L. Carrasco, and M. Esteban. 2006. Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR. Genes Dev. 20:87-100.
47. Vijaysri, S., L. Talasela, A. A. Mercer, C. J. McInnes, B. L. Jacobs, and J. O. Langland. 2003. The Orf virus E3L homologue is able to complement deletion of the vaccinia virus E3L gene in vitro but not in vivo. Virology 314:305-314.
48. Wilson, C., H. J. Bellen, and W. J. Gehring. 1990. Position effects on eukaryotic gene expression. Annu. Rev. Cell Biol. 6:679-714.
49. nA) in interferon-treated cells. Nucleic Acids Res. 9:1571-1581.
50. Xiang, Y., R. C. Condit, S. Vijaysri, B. Jacobs, B. R. Williams, and R. H. Silverman. 2002. Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus. J. Virol. 76:5251-5259.
51. Yuwen, H., J. H. Cox, J. W. Yewdell, J. R. Bennink, and B. Moss. 1993. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology 195:732-744.